Pharmacists are educators and important partners in patient care. Often on the front lines of care, pharmacists dispense more than medication. Offering expert counseling and recommendations, pharmacists serve as medication experts on care teams. As pharmacy practice scope continues to broaden, so do pharmacists’ education needs.
CME Outfitters Pharmacist Central is committed to providing evidence and outcomes-based educational activities to help pharmacists stay up-to-date on the latest data, best practices, and innovations while earning CPE credits and improving patient outcomes. Check back often and please feel free to contact us at info@cmeoutfitters.com with questions, or with any information you feel would be helpful to have on CMEO Pharmacist Central.
The first episode of this CMEO BriefCase series on halting drivers of CKD progression will present a case study that will show when a patient with T2DM should undergo guideline-recommended screening with urine albumin excretion (UACR) and estimated glomerular filtration rate (eGFR) for early diagnosis of CKD.
In this CMEO BriefCase, expert faculty will utilize a patient case to show the pathophysiological features of CKD and assess new efficacy and safety data for current and emerging therapies for CKD in patients with T2DM with a goal of improving co-management strategies.
The second installment of this CME Outfitters BriefCase series on addressing the opioid epidemic in our communities focuses on educating patients about their pain and about nonopioid pain management.
In this CMEO BriefCase, Drs. Pruitt and Wattana will guide learners through a patient case scenario reviewing the recognition of ICI exposure through focused medication history, signs and symptoms of irAEs, and principles of early, appropriate management and the importance of consultation with an oncology care team. This program will focus on the role of the ED pharmacist in making timely interventions for patients with irAEs seen in the emergency department including strategies for engaging with ED team members and for setting the patient up for a successful transition in care.
In this CMEO BriefCase, expert faculty will present information on how healthcare disparities impact irAE recognition and management and pharmacist considerations for social determinants of health relative to irAE diagnosis and treatment planning. Discussion will include strategies for addressing healthcare inequities in order to improve timely recognition and treatment for all patients experiencing irAEs.